| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |